The metabolic syndrome phenotype is associated with raised circulating Big endothelin-1 independently of coronary artery disease in type 2 diabetes

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 1, Issue 4, 2007, Pages 229-237

  Hermans, Michel P ^a   Ahn, Sylvie A ^a   Gruson, Damien ^a   Rousseau, Michel F ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Big endothelin 1; Coronary artery disease; Metabolic syndrome; Type 2 diabetes mellitus

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NATRIURETIC FACTOR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE MARKER; FEMALE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN SENSITIVITY; INSULINEMIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR DISEASE;

EID: 35448991200     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2007.09.001     Document Type: Article

References (24)

1. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
2. Sadikot S.M., and Misra A. The metabolic syndrome: an exercise in utility or futility?. Diabetes Metab Syndr Clin Res Rev 1 (2007) 3-21
3. Hermans M.P., Ahn S.A., and Rousseau M.F. The non-HDL-C/HDL-C ratio provides cardiovascular risk stratification similar to the ApoB/ApoA1 ratio in diabetics: comparison with reference lipid markers. Diabetes Metab Syndr Clin Res Rev 1 (2007) 23-28
4. Ahmad J., Khan A.R., Ahmed F., and Siddiqui S. Non-HDL cholesterol versus apolipoprotein B in the identification of dyslipidemic phenotypes associated with cardiovascular risk in type 2 diabetic dyslipoproteinemia. Diabetes Metab Syndr Clin Res Rev 1 (2007) 29-36
5. Rousseau M.F., Konstam M.A., Benedict C.R., Donckier J., Galanti L., Melin J., et al. Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor. Am J Cardiol 73 (1994) 488-493
6. Selvais P.L., Robert A., Ahn S., van Linden F., Ketelslegers J.M., Pouleur H., et al. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. J Card Fail 6 (2000) 201-207
7. Rousseau M.F., et al. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure. Results from the Rales Neurohormonal Substudy. J Am Coll Cardiol 40 (2002) 1596-1601
8. Van Beneden R., Gurné O., Selvais P.L., Ahn S.A., Robert A.R., Ketelslegers J.M., et al. Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study. J Card Fail 10 (2004) 490-495
9. Wheatcroft S.B., Williams I.L., Shah A.M., and Kearney M.T. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 20 (2003) 255-268
10. Kim J.-A., Montagnani M., Koh K.K., and Quon M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction. Molecular and pathophysiological mechanisms. Circulation 113 (2006) 1888-1904
11. Jiang Z.Y., Zhou Q.L., Chatterjee A., Feener E.P., Myers M.G., White M.F., et al. Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes 48 (1999) 1120-1130
12. Lteif A., and Mather K. Insulin resistance, metabolic syndrome and vascular diseases: update and mechanistic linkages. Can J Cardiol 20 Suppl. B (2004) 66B-76B
13. Stanger O., and Weger M. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium. Clin Chem Lab Med 41 (2003) 1444-1454
14. Shaw S.G., and Boden P.J. Insulin resistance, obesity and the metabolic syndrome. Is there a therapeutic role for endothelin-1 antagonists?. Curr Vasc Pharmacol 3 (2005) 359-363
15. Sarafidis P.A., and Bakris G.L. Insulin and endothelin: an interplay contributing to hypertension development?. J Clin Endocrinol Metab 92 (2007) 379-385
16. Ahlborg G., and Lindstrom J. Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humans. J Appl Physiol 93 (2002) 2112-2121
17. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
18. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002;106:3143-421.
19. Kothari V., Stevens R.J., Adler A.I., Stratton I.M., Manley S.E., Neil H.A., et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 33 (2002) 1776-1781
20. Levy J.C., Matthews D.R., and Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21 (1998) 2191-2192
21. Hermans M.P., Levy J.C., Morris R.J., and Turner R.C. Comparison of tests of β-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 48 (1999) 1779-1786
22. Hermans M.P., Levy, Morris R.J., and Turner R.C. Comparison of insulin sensitivity tests across a range of glucose tolerance form normal to diabetes. Diabetologia 42 (1999) 678-687
23. Hermans M.P. Diabetes and the endothelium. Acta Clin Belg 62 (2007) 97-101
24. Lteif A., Vaishnava P., Baron A.D., and Mather K.J. Endothelin limits insulin action in obese/insulin-resistant humans. Diabetes 56 (2007) 728-734